Shyam Mani, MD
Internal Medicine · Houma, LANPI 1780029645
Payments from drug & device makers
Across 46 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$217
- Novartis$173
- Johnson & Johnson$139
- Astellas Pharma US Inc$108
- Daiichi Sankyo Inc.$82
- Bristol Myers Squibb$73
- plus $313 from 10 others
What the payments were for
- Food & beverage$1,00291%
- Education$1029%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $217 |
| Novartis | 9 | $173 |
| Johnson & Johnson | 5 | $139 |
| Astellas Pharma US Inc | 2 | $108 |
| Daiichi Sankyo Inc. | 3 | $82 |
| Bristol Myers Squibb | 3 | $73 |
| Merck | 2 | $54 |
| Bayer | 2 | $47 |
| Sanofi | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Sobi, Inc | 1 | $31 |
| Incyte Corporation | 1 | $24 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Caris MPI, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
How this compares
$1,104 in reported general payments places this provider in the 65th percentile of 1,528 internal medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 18 | $310,537 |
| EliquisApixaban | 24 | $23,753 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $1,153 |
| Ondansetron OdtOndansetron | 17 | $867 |
| Anastrozole | 54 | $308 |
| Olanzapine | 24 | $257 |
| Oxycodone Hcl | 17 | $241 |
| Ondansetron Hcl | 13 | $240 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $208 |
| Tizanidine Hcl | 12 | $169 |
| Alendronate Sodium | 36 | $168 |
| Dexamethasone | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Houma
- William SmithNew Orleans$50.5M
- Robert JeanfreauMetairie$13.4M
- Katherine PearceBaton Rouge$12M
- Ernest ThompsonBaker$2.1M
- Brian LewisNew Orleans$2M
- Otis BarnumNatchitoches$1.8M
- Satinder SainiCrowley$1.8M
- Randall MillerEunice$1.2M
- Donna RyanBaton Rouge$991K
- Steven DeitelzweigNew Orleans$939K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.